ULTRAGENYX PHARMACEUTICAL

ultragenyx-pharmaceutical-logo

Ultragenyx Pharmaceutical develops therapeutics for rare diseases, sometimes referred to as Orphan products. Ultragenyx is a efficient and effective development strategies are essential for success in the rare disease space, in which information may be incomplete or ambiguous, and few development precedents exist. The management team's experience in selecting and developing products with clear mechanisms of action for untreated rare diseases will help Ultragenyx create life-changing therapeutics by leveraging existing yet undeveloped science for these little-known indications.

#SimilarOrganizations #People #Financial #Event #Website #More

ULTRAGENYX PHARMACEUTICAL

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2010-01-01

Address:
Novato, California, United States

Country:
United States

Website Url:
http://www.ultragenyx.com

Total Employee:
501+

Status:
Active

Contact:
+1 415 483 8800

Email Addresses:
[email protected]

Total Funding:
185 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Google Tag Manager WordPress Sitelinks Search Box Euro Amazon Yoast WordPress SEO Plugin Yoast SEO Premium


Similar Organizations

acelrx-pharmaceuticals-logo

AcelRx Pharmaceuticals

AcelRx Pharmaceuticals focuses on the development and commercialization of therapies for the treatment of pain and other conditions.

alexza-pharmaceuticals-logo

Alexza Pharmaceuticals

Alexza Pharmaceuticals is a pharmaceutical company developing novel products for the treatment of acute and intermittent conditions.

anthera-pharmaceuticals-logo

Anthera Pharmaceuticals

Anthera Pharmaceuticals is focused on developing products to treat diseases associated with inflammation and autoimmune diseases.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

apexigen-logo

Apexigen

Apexigen is a clinical-stage biopharmaceutical company discovering and developing a new generation of antibody therapeutics.

aradigm-logo

Aradigm

Aradigm is a pharmaceutical company focused on the development of drugs for the treatment of severe respiratory diseases.

cellix-bio-logo

Cellix Bio

Cellix Bio provides medical research services to develop drug products for the treatment of immune and other related diseases.

enbiotix-logo

EnBiotix

EnBiotix advances front-line labeled products for chronic, recurrent, and life-threatening pulmonary infections.

eolo-pharma-logo

Eolo Pharma

Eolo Pharma focuses on developing drugs targeting the molecular and cellular basis of inflammation-related diseases

forendo-pharma-logo

Forendo Pharma

Forendo Pharma is a developer of novel drugs intended for the treatment of urological and other endocrinological diseases.

idera-pharmaceuticals-logo

Idera Pharmaceuticals

Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.

imricor-medical-systems-logo

Imricor Medical Systems

Imricor Medical Systems develops magnetic resonance imaging compatible electrophysiology tools for the treatment of cardiac arrhythmias.

innovus-pharmaceuticals-logo

Innovus Pharmaceuticals

Innovus Pharmaceuticals develops healthcare products for dermatology, autoimmune, respiratory, and sexual dysfunction diseases.

intelgenx-logo

IntelGenX

IntelGenX is an oral drug delivery company primarily that focuses on the development and manufacturing of pharmaceutical oral films.

karuna-therapeutics-logo

Karuna Therapeutics

Karuna Therapeutics is a Massachusetts-based developer of drugs for the treatment of schizophrenia.

melt-pharmaceuticals-logo

Melt Pharmaceuticals

Melt Pharmaceuticals focuses on developing novel approach to providing procedural sedation and analgesia for short-term medical procedures.

mithra-pharmaceuticals-sa-logo

Mithra Pharmaceuticals SA

Mithra Pharmaceuticals SA specializes in the development of women's health care products.

musclepharm-logo

MusclePharm

MusclePharm provides sports nutrition products and supplements for athletes of all kinds.

neurana-pharmaceuticals-logo

Neurana Pharmaceuticals

Neurana Pharmaceuticals is currently developing a novel treatment for acute muscle spasms.

orphion-therapeutics-logo

Orphion Therapeutics

Orphion Therapeutics is focused on the development of novel gene therapies for the treatment of rare and serious genetic disorders.

pbs-biotech-logo

PBS Biotech

PBS Biotech is produces the easiest to use and most technologically-advanced bioreactors for the pharmaceutical industry.

santhera-pharmaceuticals-logo

Santhera Pharmaceuticals

Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.

synerkine-pharma-logo

Synerkine Pharma

Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.

tetralogic-pharmaceuticals-logo

TetraLogic Pharmaceuticals

TetraLogic Pharmaceuticals discovers and develops small molecule drugs for theย treatment ofย debilitating diseases and conditions.

waterstone-pharmaceuticals-logo

Waterstone Pharmaceuticals

Waterstone Pharmaceuticals is engaged in the development of various drugs for the treatment of liver and gastrointestinal diseases.

westlake-therapeutics-logo

Westlake Therapeutics

The company is committed to the development of a variety of innovative cell therapy products for rare diseases, cancer, etc.

zs-pharma-logo

ZS Pharma

ZS Pharma develops ion trap therapies for the treatment of life-threatening medical conditions such as hyperkalemia and liver diseases.


Current Advisors List

eran-nadav_image

Eran Nadav Chairman of the Board @ Ultragenyx Pharmaceutical
Board_member

marten-steen_image

Marten Steen Board of Directors @ Ultragenyx Pharmaceutical
Board_member

matthew-fust_image

Matthew Fust Board of Directors @ Ultragenyx Pharmaceutical
Board_member

Current Employees Featured

kenneth-lowe_image

Kenneth Lowe
Kenneth Lowe Director @ Ultragenyx Pharmaceutical
Director
2022-03-01

yael-weiss_image

Yael Weiss
Yael Weiss VP Business Development @ Ultragenyx Pharmaceutical
VP Business Development
2017-04-01

christine-murray_image

Christine Murray
Christine Murray Senior Advisor, Development @ Ultragenyx Pharmaceutical
Senior Advisor, Development
2021-09-01

not_available_image

John Pinion
John Pinion EVP Translational Sciences, Chief Quality Operations Officer @ Ultragenyx Pharmaceutical
EVP Translational Sciences, Chief Quality Operations Officer

not_available_image

Camille Bedrosian
Camille Bedrosian Chief Medical Officer & Executive Vice President @ Ultragenyx Pharmaceutical
Chief Medical Officer & Executive Vice President

carolyn-wang_image

Carolyn Wang
Carolyn Wang SVP, Global Corporate Communications @ Ultragenyx Pharmaceutical
SVP, Global Corporate Communications
2021-05-01

not_available_image

Dennis Huang
Dennis Huang Chief Technical Operations Officer; EVP Gene Therapy Operations @ Ultragenyx Pharmaceutical
Chief Technical Operations Officer; EVP Gene Therapy Operations

yael-weiss_image

Yael Weiss
Yael Weiss Executive Director, Search and Evaluation, Business Development @ Ultragenyx Pharmaceutical
Executive Director, Search and Evaluation, Business Development
2014-11-01

not_available_image

Thomas Kassberg
Thomas Kassberg Chief Business Officer and Senior Vice President @ Ultragenyx Pharmaceutical
Chief Business Officer and Senior Vice President

claudia-bertrams_image

Claudia Bertrams
Claudia Bertrams Senior Director Supply Chain Europe & APAC @ Ultragenyx Pharmaceutical
Senior Director Supply Chain Europe & APAC
2019-10-01

Founder


emil-d-kakkis_image

Emil D. Kakkis

Stock Details


Company's stock symbol is NASDAQ:RARE

Acquisitions List

Date Company Article Price
2022-07-18 GeneTx Biotherapeutics GeneTx Biotherapeutics acquired by Ultragenyx Pharmaceutical 75 M USD
2017-09-18 Dimension Therapeutics Dimension Therapeutics acquired by Ultragenyx Pharmaceutical 152.3 M USD

Investors List

takeda-ventures_image

Takeda Ventures

Takeda Ventures investment in Post-IPO Equity - Ultragenyx Pharmaceutical

takeda-pharmaceutical_image

Takeda

Takeda investment in Post-IPO Equity - Ultragenyx Pharmaceutical

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series B - Ultragenyx Pharmaceutical

adage-capital-management_image

Adage Capital Management

Adage Capital Management investment in Series B - Ultragenyx Pharmaceutical

healthcap_image

HealthCap

HealthCap investment in Series B - Ultragenyx Pharmaceutical

pappas-ventures_image

Pappas Ventures

Pappas Ventures investment in Series B - Ultragenyx Pharmaceutical

tpg-growth_image

TPG Growth

TPG Growth investment in Series B - Ultragenyx Pharmaceutical

blackrock-private-equity-partners_image

BlackRock Private Equity Partners

BlackRock Private Equity Partners investment in Series B - Ultragenyx Pharmaceutical

healthcap_image

HealthCap

HealthCap investment in Series A - Ultragenyx Pharmaceutical

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series A - Ultragenyx Pharmaceutical

Investments List

Date Company Article Money raised
2020-10-23 Solid Biosciences Ultragenyx Pharmaceutical investment in Post-IPO Equity - Solid Biosciences 40 M USD

Newest Events participated

clinical-operations-strategy-meeting-west-coast-2018_event_image Participated in Clinical Operations Strategy Meeting West Coast 2018 on 2018-05-15 as speaker

Official Site Inspections

http://www.ultragenyx.com Semrush global rank: 921.99 K Semrush visits lastest month: 39.3 K

  • Host name: 104.18.26.199
  • IP address: 104.18.26.199
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Ultragenyx Pharmaceutical" on Search Engine